• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL FLEXNAV DELIVERY SYSTEM; Aortic valve, prosthesis, percutaneously delivered

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL FLEXNAV DELIVERY SYSTEM; Aortic valve, prosthesis, percutaneously delivered Back to Search Results
Catalog Number FNAV-DS-SM
Device Problems Difficult to Advance (2920); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/13/2023
Event Type  malfunction  
Manufacturer Narrative
An event of advancement difficulty through patient anatomy and catheter damage was reported.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Information from the field indicated that damage was observed at the opening of the catheter.The field also indicated that the patient had a high degree of calcareous plaque in the femoral artery.The device was returned for analysis.The nosecone and valve capsule were observed to be damaged/deformed.As the event is not reportable, a letter is not requested and there is no indication of a product issue, no device history record or lot specific similar complaint review is required.Based on available information, the cause of the reported event appears to be a result of calcareous plaque in the femoral artery.There is no indication of a product quality issue with respect to manufacture, design, or labeling.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Event Description
It was reported that on 13 january 2023, an unknown valve was chosen for implant using a large flexnav delivery system.It was noted that there was calcareous plaque in the femoral artery.While it was attempted to pass the delivery system through the femoral artery, resistance was encountered.The delivery system was removed, and damage was seen at the opening of the catheter.A new large flexnav delivery system was chosen to implant the valve.The valve was successfully positioned and implanted.The patient remained stable throughout the procedure and there was no clinically significant delay.The patient was reported as stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLEXNAV DELIVERY SYSTEM
Type of Device
Aortic valve, prosthesis, percutaneously delivered
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17732939
MDR Text Key323229462
Report Number2135147-2023-03960
Device Sequence Number1
Product Code NPT
UDI-Device Identifier05415067031372
UDI-Public05415067031372
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P190023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 09/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberFNAV-DS-SM
Device Lot Number8767326
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/17/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/21/2023
Initial Date FDA Received09/12/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/18/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-